Human glioma tumors express high levels of the chemokine receptor CX3CR1
Marco Locatelli1, Leonardo Boiocchi1,2, Stefano Ferrero2, Filippo Martinelli Boneschi3, Mario Zavanone1,4, Samantha Pesce5, Paola Allavena5, Sergio Maria Gaini1,4, Lorenzo Bello1,4, Alberto Mantovani5,6
European Cytokine Network, Vol.21, No.1, pp. 27-33, 2010, DOI:10.1684/ecn.2009.0184
Abstract The chemokine receptor CX3CR1 and its cognate ligand CX3CL1 (also known as fractalkine), are
involved in central nervous system pathophysiology, in particular, in the cross-talk between neurons and micro-glia.
It was therefore important to investigate the expression of CX3CR1 in gliomas, the most frequently occur-ring,
malignant brain tumors. In a consecutive series of 70 patients with primary, central nervous glial tumors,
CX3CR1 was highly expressed in tumor cells as assessed by RT-PCR mRNA and protein levels, and by immu-nohistochemistry,
while the corresponding normal cells were negative. Receptor immuno-positivity did not
correlate with histology, grade, chromosomal More >